Relationship of urinary isoprostanes to prostate cancer occurence

Molecular and Cellular Biochemistry

Volumn 372, Issue 1-2, 2013, Pages 149-153

  Brys, Magdalena ^a   Morel, Agnieszka ^a   Forma, Ewa ^a   Krzeslak, Anna ^a   Wilkosz, Jacek ^b   Rozanski, Waldemar ^b   Olas, Beata ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Isoprostanes; Oxidative stress; Prostate cancer; Uric acid

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; BIOLOGICAL MARKER; GLUCOSE; ISOPROSTANE; PROSTATE SPECIFIC ANTIGEN; REACTIVE OXYGEN METABOLITE; UNSATURATED FATTY ACID; URIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; OXIDATIVE STRESS; PROSTATE CANCER; URINE LEVEL;

AGED; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DINOPROST; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; NEOPLASM GRADING; ORGAN SIZE; OXIDATIVE STRESS; PROSTATE; PROSTATIC NEOPLASMS; RISK; TUMOR MARKERS, BIOLOGICAL; URIC ACID;

EID: 84870400154     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1455-z     Document Type: Article

References (19)

1. Afanas'ev I (2011) Reactive oxygen species signaling in cancer: comparison with aging. Aging Dis 2:219-230
2. Barocas DA, Motley S, Cookson MS, Chang SS, Penson DFP, Dai Q, Milne G, Jackson L, Morrow RJ, Concepcion RS, Smith JA, Fowke JH (2011) Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer. J Urol 185:2102-2107
3. Adighatla MR, Hatcher JF (2008) Altered lipid metabolism in brain injury disorders. Subcell Biochem 49:241-268
4. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87:9383-9387
5. Cracowski JL, Durand T (2006) Cardiovascular pharmacology and physiology of the isoprostanes. Fundam Clin Pharmacol 20:417-427
6. Basu S (2004) Isoprostanes: novel bioactive products of lipid peroxidation. Free Radic Res 38:105-122
7. 2- isoprostane biosynthesis and inhibition in man. Chem Phys Lipids 128:149-163
8. 2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28:505-513
9. Roberts LJ, Fessel JP (2004) The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Chem Phys Lipids 128:173-186
10. Fam SS, Morrow JD (2003) The isoprostanes: unique products of arachidonic acid oxidation. Curr Med Chem 10:1723
11. 2-isoprostanes on retinal and cerebral microvasculature. Free Radic Biol Med 6:163-172
12. 3-isoprostanes) in vivo from eicosapentaenoic acid. J Biol Chem 281:14092-14099
13. Kim KM, Henderson GN, Ouyang X, Frye RF, Sautin YY, Feig DI, Johnson RJ (2009) A sensitive and specific liquid chromatography-tandem mass spectrometry method for the determination of intracellular and extracellular uric acid. J Chromatogr B Anal Technol Biomed Life Sci 877:2032-2038
14. Sanguinetti SM, Batthyany C, Trostchansky A, Botti H, Lopez GI, Wikinski RL, Rubbo H, Schreier LE (2004) Nitric oxide inhibits prooxidant actions of uric acid during copper-mediated LDL oxidation. Arch Biochem Biophys 15:302-308
15. Lawson JA, Rokach J, Fitzgerald GA (1999) Isoprostanes: formation, analysis, and use as indices of lipid peroxidation in vivo. J Biol Chem 274:24441-24444
16. Montuschi P, Barnes P, Roberts JL (2004) Isoprostanes: markers and mediators of oxidative stress. The FOSEB J 18:1792-1796
17. 2-Isoprostanes: a marker of oxidative stress in vivo. Biomarkers 1:S10-S23
18. 2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol 433:113-126
19. Young IS, Woodside JY (2001) Antioxidants in health and disease. J Clin Pathol 54:176-186